The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
AGICAP
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Acces GIR
Login
Català
Castellano
English
The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
AGICAP
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Search
Most popular
COL·LABORA
Menu
English
Català
Español
Home
USR Unitat Transversal de Recerca
USR Unitat Transversal de Recerca
Presentation
Team
Groups
Publications
Projects
News
Presentation
Team
Groups
Publications
Projects
News
Projects
Group projects
Exploratory study for PASS of Trimetazidine_Servier
Principal investigators:
Rosa Morros Pedrós
Code:
9F14/006
Start year:
2014
Funders:
Laboratorios Servier, S.L.
Post-Authorization Safety Study of Agomelatine and the Risk of Hospitalisation for Liver Injury
Principal investigators:
Rosa Morros Pedrós
Code:
9F14/007
Start year:
2014
Funders:
Research Triangle Institute (RTI)
Eosinofilies i EPOC (Astra-Zeneca)
Principal investigators:
Mònica Monteagudo Zaragoza
Code:
9F14/008
Start year:
2014
Two phase 3 CV outcome studies with bi-weekly subcutaneous PCSK9 inhibitor treatment (compared to placebo)
Principal investigators:
Rosa Morros Pedrós
Code:
9F14/009
Start year:
2014
Two phase 3 CV outcome studies with bi-weekly subcutaneous PCSK9 inhibitor treatment (compared to placebo)
Principal investigators:
Rosa Morros Pedrós
Code:
9F14/010
Start year:
2014
Anterior
1
…
70
71
72
73
74
…
78
Següent
Board of Trustees
Collaborators
Accreditations